×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
HAE – haemonetics corporation (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
HAE
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/18
08:06 am
hae
Haemonetics Co. (NYSE: HAE) had its price target lowered by analysts at Needham & Company LLC from $108.00 to $104.00. They now have a "buy" rating on the stock.
Low
Report
Haemonetics Co. (NYSE: HAE) had its price target lowered by analysts at Needham & Company LLC from $108.00 to $104.00. They now have a "buy" rating on the stock.
3/3
04:40 pm
hae
Haemonetics Announces Executive Leadership Updates [Yahoo! Finance]
Low
Report
Haemonetics Announces Executive Leadership Updates [Yahoo! Finance]
3/3
04:10 pm
hae
Haemonetics Announces Executive Leadership Updates
Low
Report
Haemonetics Announces Executive Leadership Updates
2/24
06:11 am
hae
Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference [Yahoo! Finance]
Medium
Report
Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference [Yahoo! Finance]
2/24
06:00 am
hae
Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference
Medium
Report
Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference
2/15
01:04 am
hae
Haemonetics Co. (NYSE: HAE) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
Haemonetics Co. (NYSE: HAE) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
2/7
10:36 pm
hae
Haemonetics Co. (NYSE: HAE) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Low
Report
Haemonetics Co. (NYSE: HAE) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
2/7
12:49 pm
hae
Haemonetics Co. (NYSE: HAE) had its "strong-buy" rating re-affirmed by analysts at Raymond James. They now have a $115.00 price target on the stock, down previously from $120.00.
Low
Report
Haemonetics Co. (NYSE: HAE) had its "strong-buy" rating re-affirmed by analysts at Raymond James. They now have a $115.00 price target on the stock, down previously from $120.00.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/3
04:13 pm
hae
Form 8-K HAEMONETICS CORP For: Mar 03
Low
Report
Form 8-K HAEMONETICS CORP For: Mar 03
2/6
06:21 am
hae
Form 10-Q HAEMONETICS CORP For: Dec 28
High
Report
Form 10-Q HAEMONETICS CORP For: Dec 28
2/6
06:19 am
hae
Form 8-K HAEMONETICS CORP For: Feb 06
High
Report
Form 8-K HAEMONETICS CORP For: Feb 06
1/14
06:21 am
hae
Form 8-K HAEMONETICS CORP For: Jan 14
Low
Report
Form 8-K HAEMONETICS CORP For: Jan 14
1/3
06:08 am
hae
Form 8-K HAEMONETICS CORP For: Dec 27
Low
Report
Form 8-K HAEMONETICS CORP For: Dec 27
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
8/6
Q1/2020 6/29/2019 EPS 0.810 ZacksConsensus 0.630 ActVsEst 0.180 - Beat
12.0%
2/4 Q3/2020 12/28/2019 EPS 0.940 ZacksConsensus 0.760 ActVsEst 0.180 - Beat 9.5%
4/2 Haemonetics Acquires enicor GmbH to Expand Advanced Viscoelastic Testing Portfolio 8.9%
11/1 Q2/2020 9/28/2019 EPS 0.870 ZacksConsensus 0.720 ActVsEst 0.150 - Beat 7.2%
2/5 Haemonetics Co. (NYSE: HAE) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $142.00 price target on the stock. 7.2%
5/13 Form 5 HAEMONETICS CORP For: Mar 30 Filed by: KROLL MARK W 5.8%
4/13 Form 4 HAEMONETICS CORP For: Apr 09 Filed by: KROLL MARK W 5.1%
4/17 Michael Coyle Joins Haemonetics Board of Directors 4.7%
5/7 Q4/2019 3/30/2019 EPS 0.610 ZacksConsensus 0.550 ActVsEst 0.060 - Beat 4.4%
8/12 Form 4 HAEMONETICS CORP For: Aug 09 Filed by: Goldstein Dan 3.2%
2/4 Q3/2020 12/28/2019 EPS 0.940 ZacksConsensus 0.760 ActVsEst 0.180 - Beat 9.5%
4/2 Haemonetics Acquires enicor GmbH to Expand Advanced Viscoelastic Testing Portfolio 8.9%
11/1 Q2/2020 9/28/2019 EPS 0.870 ZacksConsensus 0.720 ActVsEst 0.150 - Beat 7.2%
2/5 Haemonetics Co. (NYSE: HAE) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $142.00 price target on the stock. 7.2%
5/13 Form 5 HAEMONETICS CORP For: Mar 30 Filed by: KROLL MARK W 5.8%
4/13 Form 4 HAEMONETICS CORP For: Apr 09 Filed by: KROLL MARK W 5.1%
4/17 Michael Coyle Joins Haemonetics Board of Directors 4.7%
5/7 Q4/2019 3/30/2019 EPS 0.610 ZacksConsensus 0.550 ActVsEst 0.060 - Beat 4.4%
8/12 Form 4 HAEMONETICS CORP For: Aug 09 Filed by: Goldstein Dan 3.2%
TOP News Decliners
4/7
Haemonetics Co. (NYSE: HAE) had its price target lowered by analysts at Raymond James from $150.00 to $130.00. They now have an "outperform" rating on the stock.
-8.2%
11/2 Haemonetics (HAE) Q2 2020 Earnings Call Transcript [The Motley Fool] -6.5%
1/23 Haemonetics Co. (NYSE: HAE) had its price target lowered by analysts at Raymond James from $150.00 to $145.00. They now have an "outperform" rating on the stock. -4.8%
5/22 Form 10-K HAEMONETICS CORP For: Mar 30 -3.3%
3/30 Haemonetics Appoints Anila Lingamneni Executive Vice President, Chief Technology Officer -2.8%
5/11 Haemonetics Corporation (HAE) CEO Chris Simon on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] -2.7%
5/24 Form 4 HAEMONETICS CORP For: May 22 Filed by: Simon, Christopher -2.6%
9/3 Form 4 HAEMONETICS CORP For: Aug 30 Filed by: Bolorforosh Said -2.1%
2/4 Form 10-Q HAEMONETICS CORP For: Dec 28 -2.0%
9/9 Form 4 HAEMONETICS CORP For: Sep 05 Filed by: Llorens Josep -1.7%
11/2 Haemonetics (HAE) Q2 2020 Earnings Call Transcript [The Motley Fool] -6.5%
1/23 Haemonetics Co. (NYSE: HAE) had its price target lowered by analysts at Raymond James from $150.00 to $145.00. They now have an "outperform" rating on the stock. -4.8%
5/22 Form 10-K HAEMONETICS CORP For: Mar 30 -3.3%
3/30 Haemonetics Appoints Anila Lingamneni Executive Vice President, Chief Technology Officer -2.8%
5/11 Haemonetics Corporation (HAE) CEO Chris Simon on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] -2.7%
5/24 Form 4 HAEMONETICS CORP For: May 22 Filed by: Simon, Christopher -2.6%
9/3 Form 4 HAEMONETICS CORP For: Aug 30 Filed by: Bolorforosh Said -2.1%
2/4 Form 10-Q HAEMONETICS CORP For: Dec 28 -2.0%
9/9 Form 4 HAEMONETICS CORP For: Sep 05 Filed by: Llorens Josep -1.7%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: